-
1
-
-
0004134409
-
-
Adelaide: Australian Medicines Handbook Pty Ltd
-
1. Australian Medicines Handbook Pty Ltd. (2000) Australian Medicines Handbook. 2nd edn. Adelaide: Australian Medicines Handbook Pty Ltd, 14-6-14-7.
-
(2000)
Australian Medicines Handbook. 2nd Edn.
, pp. 146-147
-
-
-
3
-
-
0031906397
-
The role of corticosteroids in rheumatology
-
3. Dorai-Raj A, Schrieber L. (1998) The role of corticosteroids in rheumatology. Australian Prescriber, 21, 11-14.
-
(1998)
Australian Prescriber
, vol.21
, pp. 11-14
-
-
Dorai-Raj, A.1
Schrieber, L.2
-
4
-
-
0004105534
-
-
Melbourne: Therapeutic Guidelines Ltd
-
4. Therapeutic Guidelines Endocrinology Writing Group. (1997) Therapeutic Guidelines: Endocrinology. Melbourne: Therapeutic Guidelines Ltd, 11-12.
-
(1997)
Therapeutic Guidelines: Endocrinology
, pp. 11-12
-
-
-
5
-
-
0032901222
-
Steroid-induced osteoporosis. Are your asthmatic patients at risk?
-
5. Niewoehner DE, Niewoehner CB. (1999) Steroid-induced osteoporosis. Are your asthmatic patients at risk? Postgraduate Medicine, 105, 79-92.
-
(1999)
Postgraduate Medicine
, vol.105
, pp. 79-92
-
-
Niewoehner, D.E.1
Niewoehner, C.B.2
-
6
-
-
0031778738
-
Pathogenesis and treatment of glucocorticoid-induced osteoporosis
-
6. Rackoff PJ, Rosen CJ. (1998) Pathogenesis and treatment of glucocorticoid-induced osteoporosis. Drugs & Aging, 12, 477-484.
-
(1998)
Drugs & Aging
, vol.12
, pp. 477-484
-
-
Rackoff, P.J.1
Rosen, C.J.2
-
9
-
-
0033594676
-
Prevention of corticosteroid induced osteoporosis. Should be easier if doctors follow the recent guidelines
-
9. Lips P. (1999) Prevention of corticosteroid induced osteoporosis. Should be easier if doctors follow the recent guidelines [editorial]. British Medical Journal, 318, 1366-1367.
-
(1999)
British Medical Journal
, vol.318
, pp. 1366-1367
-
-
Lips, P.1
-
10
-
-
0032564192
-
Management of corticosteroid-induced osteoporosis
-
10. Stevenson JC. (1998) Management of corticosteroid-induced osteoporosis [editorial]. Lancet, 352, 1327-1328.
-
(1998)
Lancet
, vol.352
, pp. 1327-1328
-
-
Stevenson, J.C.1
-
11
-
-
0032977437
-
Prevention of corticosteroid-induced osteoporosis and fractures
-
11. O'Mahony D. (1999) Prevention of corticosteroid-induced osteoporosis and fractures [commentary]. Journal of Clinical Pharmacy and Therapeutics, 24, 83-85.
-
(1999)
Journal of Clinical Pharmacy and Therapeutics
, vol.24
, pp. 83-85
-
-
O'Mahony, D.1
-
12
-
-
0033246518
-
Dangerous drugs in osteoporosis
-
12. Phillips P, Braddon J. (1999) Dangerous drugs in osteoporosis. Current Therapeutics, 40(5), 56-65.
-
(1999)
Current Therapeutics
, vol.40
, Issue.5
, pp. 56-65
-
-
Phillips, P.1
Braddon, J.2
-
13
-
-
0041981884
-
Quality of life related to fear of falling and hip fracture in older women: A time trade off study
-
13. Salkeld G, Cameron ID, Cumming RG, et al. (2000) Quality of life related to fear of falling and hip fracture in older women: a time trade off study. British Medical Journal, 320, 341-346.
-
(2000)
British Medical Journal
, vol.320
, pp. 341-346
-
-
Salkeld, G.1
Cameron, I.D.2
Cumming, R.G.3
-
15
-
-
0029787602
-
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross-sectional study
-
15. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. (1996) Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross-sectional study. British Medical Journal, 313, 344-346.
-
(1996)
British Medical Journal
, vol.313
, pp. 344-346
-
-
Walsh, L.J.1
Wong, C.A.2
Pringle, M.3
Tattersfield, A.E.4
-
16
-
-
0033495980
-
Prevention of corticosteroid-induced osteoporosis: Results of a patient survey
-
16. Buckley LM, Marquez M, Feezor R, Ruffin DM, Benson LL. (1999) Prevention of corticosteroid-induced osteoporosis: results of a patient survey. Arthritis and Rheumatism, 42, 1736-1739.
-
(1999)
Arthritis and Rheumatism
, vol.42
, pp. 1736-1739
-
-
Buckley, L.M.1
Marquez, M.2
Feezor, R.3
Ruffin, D.M.4
Benson, L.L.5
-
17
-
-
0032922930
-
Risk factors for osteoporosis and fracture in patients attending rheumatology outpatient clinics
-
17. Brand CA, Jolley D, Tellus M, Muirden KD, Wark JD. (1999) Risk factors for osteoporosis and fracture in patients attending rheumatology outpatient clinics. Australian and New Zealand Journal of Medicine, 29, 197-202.
-
(1999)
Australian and New Zealand Journal of Medicine
, vol.29
, pp. 197-202
-
-
Brand, C.A.1
Jolley, D.2
Tellus, M.3
Muirden, K.D.4
Wark, J.D.5
-
18
-
-
0033956772
-
The use of inhaled corticosteroids in adults with asthma
-
18. Anon (2000) The use of inhaled corticosteroids in adults with asthma. Drug and Therapeutics Bulletin, 38, 5-8.
-
(2000)
Drug and Therapeutics Bulletin
, vol.38
, pp. 5-8
-
-
-
19
-
-
0033542041
-
Systemic adverse effects of inhaled corticosteroid therapy. A systematic review and meta-analysis
-
19. Lipworth BJ. (1999) Systemic adverse effects of inhaled corticosteroid therapy. A systematic review and meta-analysis. Archives of Internal Medicine, 159, 941-955.
-
(1999)
Archives of Internal Medicine
, vol.159
, pp. 941-955
-
-
Lipworth, B.J.1
-
20
-
-
0034701480
-
Inhaled corticosteroid use and bone-mineral density in patients with asthma
-
20. Wong CA, Walsh LJ, Smith CJP, et al. (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet, 355, 1399-1403.
-
(2000)
Lancet
, vol.355
, pp. 1399-1403
-
-
Wong, C.A.1
Walsh, L.J.2
Smith, C.J.P.3
-
21
-
-
0034701479
-
Inhaled corticosteroids, bone density, and risk of fracture
-
21. Sambrook PN. (2000) Inhaled corticosteroids, bone density, and risk of fracture [commentary]. Lancet, 355, 1385.
-
(2000)
Lancet
, vol.355
, pp. 1385
-
-
Sambrook, P.N.1
-
22
-
-
0033970825
-
Current treatment strategies for rheumatoid arthritis
-
22. Matteson EL. (2000) Current treatment strategies for rheumatoid arthritis. Mayo Clinic Proceedings, 75, 69-74.
-
(2000)
Mayo Clinic Proceedings
, vol.75
, pp. 69-74
-
-
Matteson, E.L.1
-
23
-
-
0031725539
-
Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies
-
23. Braithwaite SS, Barr WG, Rahman A, Quddusi S. (1998) Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies. Post-graduate Medicine, 104(5), 163-166 171 175-6.
-
(1998)
Post-graduate Medicine
, vol.104
, Issue.5
, pp. 163-166
-
-
Braithwaite, S.S.1
Barr, W.G.2
Rahman, A.3
Quddusi, S.4
-
24
-
-
0032199145
-
Perceptions of pharmacists about adverse effects of corticosteroid therapy: Focus on osteoporosis
-
24. Hudson JQ, Small RE, Buckley L. (1998) Perceptions of pharmacists about adverse effects of corticosteroid therapy: focus on osteoporosis. Journal of the American Pharmaceutical Association, 38, 710-716.
-
(1998)
Journal of the American Pharmaceutical Association
, vol.38
, pp. 710-716
-
-
Hudson, J.Q.1
Small, R.E.2
Buckley, L.3
|